11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia.


Journal

The Journal of steroid biochemistry and molecular biology
ISSN: 1879-1220
Titre abrégé: J Steroid Biochem Mol Biol
Pays: England
ID NLM: 9015483

Informations de publication

Date de publication:
09 2021
Historique:
received: 16 12 2020
revised: 20 04 2021
accepted: 11 05 2021
pubmed: 1 6 2021
medline: 21 9 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

Hypothalamus-pituitary-gonadal (HPG)-axis disturbances are a common phenomenon in patients with classic congenital adrenal hyperplasia (CAH). 11-oxygenated androgens have been suggested to play a role in this context. Cross-sectional single center study including 89 patients (N = 42 men, N = 55 women) with classic CAH. Differences in steroid markers in men with hypogonadism and women with secondary amenorrhea with a special focus on 11-ketotestosterone (11KT) and 11β-hydroxyandrostenedione (11OHA4). Hypogonadotropic hypogonadism was present in 23 % of men and 61 % of those women currently not on contraceptives suffered from irregular menstrual cycles or amenorrhea. Testicular adrenal rest tumor (TART) was documented in 28 % of men. 11KT (3.5x) and 11OHA4 (5.7x) among other adrenal steroids were significantly elevated in men with hypogonadism and in women with amenorrhea in comparison to those with a regular cycle (11KT: 5.2x; 11OHA4: 3.7x). 11-oxygenated androgens were not higher in men with TART than in those without. There was a negative association of 11KT and 11OHA4 with FSH but not with LH in men. As expected, all steroids were strongly correlated with each other and cases of disproportionally elevated 11-oxygenated androgens that could explain for HPG-disturbances or TART in otherwise controlled patients were rare and also found in eugonadal individuals. In CAH, 11-oxygenated androgens are elevated in women with menstrual disturbances and in men with hypogonadotropic hypogonadism. Due to the close correlation of 11-oxygenated androgens with other adrenal steroids it remains to be shown if their measurement is superior to conventional markers of androgen control.

Identifiants

pubmed: 34058329
pii: S0960-0760(21)00114-X
doi: 10.1016/j.jsbmb.2021.105921
pii:
doi:

Substances chimiques

Androgens 0
Testosterone 3XMK78S47O
Androstenedione 409J2J96VR
11-hydroxyandrostenedione 564-32-9
17-alpha-Hydroxyprogesterone 68-96-2
11-ketotestosterone KF38W1A85U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105921

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Matthias K Auer (MK)

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany.

Luisa Paizoni (L)

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany.

Meike Neuner (M)

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany.

Christian Lottspeich (C)

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany.

Heinrich Schmidt (H)

Department of Pediatric Endocrinology, Dr. von Haunersches Children's Hospital, Klinikum der Universität München, LMU München, Munich, Germany.

Martin Bidlingmaier (M)

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany.

James Hawley (J)

Department of Clinical Biochemistry, Manchester University Foundation NHS Trust, Manchester Academic Health Sciences Centre, Southmoor Rd, Manchester, UK.

Brian Keevil (B)

Department of Clinical Biochemistry, Manchester University Foundation NHS Trust, Manchester Academic Health Sciences Centre, Southmoor Rd, Manchester, UK.

Nicole Reisch (N)

Medizinische Klinik and Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany. Electronic address: Nicole.reisch@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH